Rodman & Renshaw initiated coverage on Scilex Holding with a new price target

6/13/24 7:16:15 AM ET

Biotechnology: Biological Products (No Diagnostic Substances)

Health Care

Rodman & Renshaw initiated coverage of Scilex Holding with a rating of Buy and set a new price target of $13.00

Save time and jump to the most important pieces.

Recent Analyst Ratings for
$SCLX

Date	Price Target	Rating	Analyst
1/27/2025	$22.00	Buy	D. Boral Capital
10/16/2024	$14.00	Buy	Alliance Global Partners
6/13/2024	$13.00	Buy	Rodman & Renshaw
10/16/2023	$4.00	Buy	B. Riley Securities
10/13/2023	$4.00	Buy	B. Riley Securities
10/9/2023	$12.00	Buy	H.C. Wainwright